1 / 10

Investor brief, October 2026

Measure bladder state, not wet fabric.

DryNight is a proposed connected system that aims to estimate bladder filling overnight and support a private cue before wetness begins.

Stage: Pre-prototype
DryNight data: None
Regulatory status: Not FDA-cleared or approved
Next milestone: Stage 0, a non-human bench feasibility phase

2 / 10

The timing gap starts before wetting.

Moisture alarms are established tools. They respond when wetting starts. DryNight asks whether an earlier, usable bladder-state signal can be detected overnight.

Proposed cue window

A hypothesis to test

Wetting begins

Moisture alarm detects

Illustrative timing model, not measured DryNight output.

3 / 10

The thesis has two independent failure points.

Can we see a repeatable signal?

Candidate sensors must distinguish a bladder-related change from posture, motion, body variation, and coupling noise.

Can a cue help without adding burden?

Sensing success does not prove that a cue wakes a child or improves the night. That question requires separate human-factors and feasibility work.

4 / 10

A proposed system, not finished hardware.

The current design brings together a sensing core, skin interface, private cue band, and charging dock. Stage 0 may change every component.

DryNight industrial design concept — Industrial design concept. Not to scale. Design in development.

5 / 10

Published precedent makes the question worth testing.

15 of 18

natural nocturnal bladder-filling cycles detected in 14 analyzed children during a single-night home feasibility session.

Kwinten et al., 2020

27 of 30

children whose full bladder was recognized before voiding during controlled urodynamic filling.

van Leuteren et al., 2018

External findings, not DryNight performance. Notifications were deactivated in the nocturnal study. Neither study tested whether a cue can rouse a sleeping child.

Competitive question

Why does this need to exist beyond SENS-U?

SENS-U is the nearest pediatric precedent and part of the competitive landscape. DryNight cannot assume an open field. It has to show that an overnight body interface, useful lead time, private cue, and family escalation plan create a distinct system that children can use repeatedly.

6 / 10

The next milestone is bench feasibility.

No human use. No product claim. One bounded technical question: is there a repeatable bladder-related signal worth putting on a body?

Signal screening
Candidate modalities, placement, motion, coupling, noise.
Body-interface bench work
Fixtures, repeatability, materials, power, thermal constraints.
Go or redirect review
Build a body-worn prototype only if the bench result supports it.

7 / 10

What can a connected-device engineering partner do?

Own the path from sensing architecture through a reviewable Stage 0 bench data package.

Sensing architecture

Coupling and body interface

Low-power electronics

Wireless and haptics

Bench prototype fabrication

Data and methods package

Review the Stage 0 work packages

8 / 10

Evidence decides whether the program advances.

Advance

A repeatable signal survives realistic bench conditions and justifies a body-worn prototype.

Redirect

The first modality or interface fails, but another bounded experiment is supported.

Stop

No candidate produces a usable signal above noise or within practical device constraints.

9 / 10

Portrait of Ndansi Elvis Nukam — Ndansi Elvis Nukam, Founder and CEO

Built from lived experience. Judged by evidence.

DryNight began with lived experience. Elvis wet the bed until age twelve. His son now lives with the same problem, and that continuity turned a private family burden into a technical question worth testing.

Founder record establishes healthcare operating context. It does not validate the device.

Read the company story

10 / 10

Help us earn the first signal.

DryNight is seeking technical collaboration and investor conversations grounded in the Stage 0 evidence milestone.

Start a conversation

What is not stated here

No public raise terms. No market-size claim. No IP claim. No traction claim. No commitment beyond a scoped conversation.